Form 8-K - Current report:
SEC Accession No. 0001558370-25-004599
Filing Date
2025-04-08
Accepted
2025-04-08 16:31:20
Documents
13
Period of Report
2025-04-04
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K xlo-20250404x8k.htm   iXBRL 8-K 45033
  Complete submission text file 0001558370-25-004599.txt   169871

Data Files

Seq Description Document Type Size
2 EX-101.SCH xlo-20250404.xsd EX-101.SCH 3400
3 EX-101.LAB xlo-20250404_lab.xml EX-101.LAB 16576
4 EX-101.PRE xlo-20250404_pre.xml EX-101.PRE 10706
15 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20250404x8k_htm.xml XML 4995
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40925 | Film No.: 25822377
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)